Primary Menu

Skip to content

PCR
Apoptosis Assays
Suppliers
Contact us

Menu

Biocat Net

Amine biocat 3.0

PCR

PCR primers

Search for:

Recent Posts

The pharyngeal nervous system orchestrates feeding behavior in planarians.
A comprehensive annotation and differential expression analysis of short and long non-coding RNAs in 16 bat genomes.
Dual Oxidase-Derived Reactive Oxygen Species Against Bacillus thuringiensis and Its Suppression by Eicosanoid Biosynthesis Inhibitors.
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Double-Stranded RNA Technology to Control Insect Pests: Current Status and Challenges.

FierceBiotechFollow

Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at http://t.co/32BWEhDPPD

FierceBiotech @FierceBiotech·

16h

Just over a month after joining Immunomedics as president and CEO, Semerjian has decided to step down due to “logistical obstacles” posed by the pandemic https://www.fiercebiotech.com/biotech/chutes-ladders-immunomedics-ceo-semerjian-out-after-short-tenure

Reply on Twitter 1266368097125986304 Retweet on Twitter 1266368097125986304 Like on Twitter 1266368097125986304 Twitter 1266368097125986304

FierceBiotech @FierceBiotech·

17h

It follows similar pacts by the likes of PPD, which is tapping another virtual trial specialist, Science 37, for its “siteless” approach to trials. https://www.fiercebiotech.com/cro/amid-pandemic-labcorp-s-cro-unit-covance-pens-decentralized-pact-medable

Reply on Twitter 1266355916384935936 Retweet on Twitter 1266355916384935936 Like on Twitter 12663559163849359361 Twitter 1266355916384935936

FierceBiotech @FierceBiotech·

18h

ASCO: “Sixteen months is very, very encouraging,” Ziopharm CEO Laurence Cooper, M.D., Ph.D., told FierceBiotech.https://www.fiercebiotech.com/biotech/asco-ziopharm-s-il-12-gene-therapy-boosts-survival-hard-to-treat-brain-cancer

Reply on Twitter 1266340641992331266 Retweet on Twitter 12663406419923312663 Like on Twitter 126634064199233126612 Twitter 1266340641992331266

FierceBiotech @FierceBiotech·

18h

Takeda says after it “engaged with more than 60 potential purchasers,” the “sale process was unsuccessful.” https://www.fiercebiotech.com/biotech/takeda-doesn-t-have-to-divest-shire-pipeline-med-as-no-one-wants-it-so-it-tosses-it-out

Reply on Twitter 1266329974119845889 Retweet on Twitter 12663299741198458892 Like on Twitter 12663299741198458896 Twitter 1266329974119845889

FierceBiotech @FierceBiotech·

18h

Finding ways to grow despite the setbacks to palovarotene will be a key part of Loew’s tenure as CEO of Ipsen. https://www.fiercebiotech.com/biotech/ipsen-names-sanofi-pasteur-ceo-loew-as-new-leader

Reply on Twitter 1266329738949394434 Retweet on Twitter 1266329738949394434 Like on Twitter 1266329738949394434 Twitter 1266329738949394434

FierceBiotech @FierceBiotech·

18h

“There are no rivals, we are competitors. The only rivals are the virus and time.” https://www.fiercebiotech.com/biotech/covid-19-vaccine-leaders-talk-up-need-for-partners-potential-for-a-working-vax-by-october

Reply on Twitter 1266329458874691586 Retweet on Twitter 12663294588746915863 Like on Twitter 126632945887469158611 Twitter 1266329458874691586

FierceBiotech @FierceBiotech·

28 May

Repare’s CRISPR-based platform identifies synthetic lethal gene pairs, which cause cell death when both genes are inactivated. https://www.fiercebiotech.com/biotech/bristol-myers-jumps-into-synthetic-lethality-65m-repare-deal

Reply on Twitter 1266014652124839936 Retweet on Twitter 1266014652124839936 Like on Twitter 12660146521248399361 Twitter 1266014652124839936

Jomsom by Catch Themes

Scroll Up

PCR
Apoptosis Assays
Suppliers
Contact us